Stay updated with breaking news from Comprehensive Molecular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to...
/PRNewswire/ -- Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to...
Share this article Share this article ResearchAndMarkets.com's offering. Non-small cell lung cancer (NSCLC) is currently the most common cancer in the world and is the leading cause of cancer mortality in men and women. Of total lung cancer incident cases, approximately 85% are the NSCLC subtype. NSCLC patients are usually diagnosed in the later stages of the disease, resulting in a poor prognosis. Since the last global market forecast (2015-2025), there have been significant changes in the treatment of patients with advanced disease, particularly in the metastatic setting. Although NSCLC i...